Position in BCYC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$605,158
+$61,563 QoQ
Shares Held
130,422
+69.9% QoQ
Ownership
0.186%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in BCYC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Point72 Asset Management, L.P. holds $2,394,472,979 across 188 Biotechnology names. BCYC ranks #138 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APLS |
Apellis Pharmaceuticals, Inc.
|
4,183,918 | $168,319,021 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
225,510 | $118,047,719 | |
| 3 | CLDX |
Celldex Therapeutics, Inc.
|
3,229,939 | $102,453,665 | |
| 4 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
846,801 | $73,646,282 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
424,750 | $71,791,245 | |
| 6 | ABVX |
Abivax S.A.
|
637,736 | $71,011,903 | |
| 7 | LEGN |
Legend Biotech Corp
|
3,886,017 | $70,298,047 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
358,634 | $67,799,757 |
All Filings in BCYC
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $605,158 | 130,422 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $543,595 | 76,779 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $3,335,166 | 430,900 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $12,319,570 | 1,772,600 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $31,345,665 | 3,692,069 | Shares | Defined | 2025-07-21 | |
| 2024-12-31 | $63,768,600 | 4,554,900 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $20,362,451 | 899,799 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,184,040 | 58,500 | Shares | Defined | 2024-09-16 | |
| 2024-03-31 | $8,530,590 | 342,594 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $4,084,181 | 225,895 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $26,106,955 | 1,299,500 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $12,198,560 | 478,000 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $17,067,048 | 802,400 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $29,836,148 | 1,007,978 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $29,201,022 | 1,255,418 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $24,247,100 | 1,445,000 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $71,076,911 | 1,619,802 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $95,737,736 | 1,572,823 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $67,171,676 | 1,615,092 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $54,828,186 | 1,805,935 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $47,119,715 | 1,577,493 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $25,804,489 | 1,437,576 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $25,968,026 | 1,363,151 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $6,303,854 | 400,499 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $5,466,811 | 400,499 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||